ArticleBMC nursing2025
Development and validation of a fall risk assessment scale for hospitalized cancer patients undergoing chemotherapy.
Article in BMC nursing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundHospitalized cancer patients undergoing chemotherapy are at high risk of falls. This study aimed to develop a Fall Risk Assessment Scale for Hospitalized Cancer Patients Undergoing Chemotherapy to provide an effective tool to prevent falls and improve patient safety.
methodsAn initial item pool was constructed using an evidence-based approach. The initial scale was refined through expert consultations and then used to assess fall risk in 329 patients. We tested the scale's reliability and validity. The optimal cut-off value was determined using Receiver Operating Characteristic (ROC) curve analysis, and risk levels were defined using a quartile-based method.
resultsThe final scale consisted of 3 dimensions (Personal factors, Chemotherapy-related symptoms and signs, and Diagnostic and treatment factors) and 12 items. Scale Content Validity Index (S-CVI) and Item Content Validity Index (I-CVI) were both 1.000. Exploratory factor analysis (EFA) extracted three factors with eigenvalues greater than 1, with a cumulative variance rate of 52.667%, and all item loadings exceeded 0.40. ROC analysis identified a cut-off of 20 points for the scale, with Area Under the Curve (AUC) = 0.742, sensitivity 94.7%, and specificity 53.3%. Based on the 20-point threshold, scores of 20-25 indicated low risk, 26-33 medium risk, and ≥ 34 high risk.
conclusionThe Fall Risk Assessment Scale for Hospitalized Cancer Patients Undergoing Chemotherapy demonstrated good reliability and validity and can be used as a clinical tool to identify and predict falls.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.